The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded a decrease of -48.37%. However, over the last six months, the performance has been stronger by -59.95%. The price of INAB decreased -27.23% over the last 30 days. And in the last five days, it has surged by 0.23%.
IN8bio Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $1.74 on 06/13/24, while the lowest price for the same duration was marked at $0.11 on 05/15/25.
52-week price history of INAB Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. IN8bio Inc’s current trading price is -92.37% away from its 52-week high, while its distance from the 52-week low is 18.57%. The stock’s price range during this period has varied between$0.11 and $1.74. The IN8bio Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.73 million for the day, a figure considerably lower than their average daily volume of 1.34 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
IN8bio Inc (INAB) has experienced a quarterly decline of -51.09% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 12.06M and boasts a workforce of 18 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2262, with a change in price of -0.1216. Similarly, IN8bio Inc recorded 3,832,142 in trading volume during the last 100 days, posting a change of -47.80%.
INAB’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for INAB stands at 0.31. Similarly, the long-term debt-to-equity ratio is also 0.22.
INAB Stock Stochastic Average
IN8bio Inc’s raw stochastic average for the past 50 days is presently 14.80%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 26.67%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 21.91% and 19.88%, respectively.
